GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Dividends per Share

Immunoclin (Immunoclin) Dividends per Share : $0.00 (TTM As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Dividends per Share?

Immunoclin's dividends per share for the three months ended in Oct. 2014 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Oct. 2014 was $0.00. Its Dividend Payout Ratio for the three months ended in Oct. 2014 was 0.00. As of today, Immunoclin's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Immunoclin Dividends per Share Historical Data

The historical data trend for Immunoclin's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Dividends per Share Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Dividends per Share
- - -

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Immunoclin's Dividends per Share

For the Biotechnology subindustry, Immunoclin's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunoclin's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Immunoclin's Dividend Yield % falls into.



Immunoclin Dividends per Share Calculation

Dividends paid to per common share.


Immunoclin  (GREY:IMCL) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Immunoclin's Dividend Payout Ratio for the quarter that ended in Oct. 2014 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Oct. 2014 )/ EPS without NRI (Q: Oct. 2014 )
=0/ -0.22
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immunoclin Dividends per Share Related Terms

Thank you for viewing the detailed overview of Immunoclin's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines